TCL Archive Fountain Hearings Turn Up Some Responsible Criticism, some Not, Much Support for Program June 24, 1977
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006